Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Neoforma Eliminating Transaction Fees For Device E-Procurement

This article was originally published in The Gray Sheet

Executive Summary

Neoforma.com's adoption of a "value sharing" business model in lieu of a transaction fee-based model could pave the way for greater participation by major device manufacturers on the e-commerce exchange.

You may also be interested in...



Clinical Process Approach To Product Development Urged By GPO Chief

Value-added service, standardization of care, and cost efficiency factors need to be incorporated into medical device product development to temper GPO members' penchant for unit price reduction, according to Premier.

Clinical Process Approach To Product Development Urged By GPO Chief

Value-added service, standardization of care, and cost efficiency factors need to be incorporated into medical device product development to temper GPO members' penchant for unit price reduction, according to Premier.

Neoforma.com Salvages Novation Deal, Scraps Eclipsys/HealthVision Merger

Online medical equipment exchange Neoforma.com is handing over a hefty 45% of its equity to national health care alliances VHA, Inc. and University HealthSystems Consortium, part of the Novation group purchasing organization, under a revised agreement announced May 25.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014689

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel